We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Guidance on the fast-track process for Nationally Significant Infrastructure Projects.
Proposed updates to NHS Constitution for England will reflect biological needs of patients and empower people to request same-sex wards and care.
Training guide for NHS and emergency services staff on rapid screening of people for internal radioactive contamination.
This guidance provides details of the PAR changes we have made for these funds, giving more flexibility to councils to change projects.
Product security factsheet accompanying the Product Security and Telecommunications Infrastructure Bill, outlining the problems the Bill will address and how.
Getting a faster decision on a visa or settlement application; priority service, super priority service; waiting times; how to check if you're eligible
How to use a quasi-experimental study to evaluate your digital health product.
Guidance for industry on flexible approaches we are taking on good distribution practices.
Announcement of 42 further Rapid Rehousing Pathway early adopters.
This form can be used to support you to identify what help and changes are available to help you move into work or stay in a job.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Examples of how and when to adjust the customs value for commercial level and quantity when using Methods 2 or 3 if you’re an importer or clearing agent.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
How to use a micro-randomised trial to evaluate your digital health product.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.